Ventricular Tachycardia Ablation Guidance Includes Randomized Studies
This article was originally published in The Gray Sheet
Executive Summary
Randomized clinical studies remain an option for sponsors seeking approval of ablation devices for the treatment of ventricular tachycardia (VT), FDA's Center for Devices and Radiological Health says in a recent guidance.